Maples-Keller Jessica L, Watkins Laura, Hellman Natalie, Phillips Nathaniel L, Rothbaum Barbara O
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.
Department of Psychology, University of Georgia, Atlanta, Georgia.
Biol Psychiatry. 2025 Feb 15;97(4):382-391. doi: 10.1016/j.biopsych.2024.07.010. Epub 2024 Jul 18.
This brief review article will describe treatment approaches for posttraumatic stress disorder (PTSD) based on findings from basic research. The focus of this review will be fear conditioning and extinction models, which provide a translational model of PTSD that can help translate basic research in nonhuman animals through well-controlled trials confirming the efficacy of treatment approaches in humans with PTSD such as prolonged exposure therapy. Specific cognitive aspects of fear extinction processes, including consolidation and reconsolidation, are reviewed along with behavioral and pharmacological treatment strategies based on basic research in these areas including attempts to prevent the development of PTSD as well as the treatment of chronic PTSD. Pharmacological, behavioral, and device-based augmentation strategies of PTSD treatment based in basic science findings are reviewed, including those that disrupt noradrenergic receptor processes, medications that act on NMDA receptors, physical exercise, cannabinoids, estradiol, dexamethasone, yohimbine, losartan, dopamine, and MDMA, along with the evidence for their efficacy in human clinical samples. While fear extinction provides an exciting translational opportunity to improve PTSD based on basic science findings, we review limitations and challenges of the extant literature as well as future directions.
这篇简短的综述文章将基于基础研究的结果描述创伤后应激障碍(PTSD)的治疗方法。本综述的重点将是恐惧条件反射和消退模型,它们提供了一个PTSD的转化模型,通过精心控制的试验,能够帮助将非人类动物的基础研究转化为对人类PTSD治疗方法疗效的确认,如延长暴露疗法。文章将回顾恐惧消退过程的特定认知方面,包括巩固和重新巩固,以及基于这些领域基础研究的行为和药物治疗策略,包括预防PTSD发展以及治疗慢性PTSD的尝试。文章还将回顾基于基础科学发现的PTSD治疗的药物、行为和基于设备的增强策略,包括那些破坏去甲肾上腺素能受体过程的策略、作用于NMDA受体的药物、体育锻炼、大麻素、雌二醇、地塞米松、育亨宾、氯沙坦、多巴胺和摇头丸,以及它们在人类临床样本中疗效的证据。虽然恐惧消退基于基础科学发现为改善PTSD提供了一个令人兴奋的转化机会,但我们也将回顾现有文献的局限性和挑战以及未来的方向。